Ingram Screening Collaborative Set for 2024

Thank you for your interest, our collaborative is beginning January 8th and all registrants have been sent the Zoom link and agenda.

If the collaborative proves useful, we will host another one in 2025 as well!

The Ingram Screening Collaborative is a joint intellectual effort by providers, patients, clients, and organizations to research, discuss, and promote Perinatal Mood & Anxiety Disorder (PMAD) screening using an Appreciative Inquiry (AI) approach. Together we will create our Mission, Vision, and Philosophy statements and create a national movement to advance and promote comprehensive screening programs and best practices across disciplines.

Collaborative schedule

Dates & Times (Quarterly Meetings/Mondays)

January 8, 2024 7:30 am - 9:00 am PST

April 8, 2024 7:30 am - 9:00 am PST

July 8, 2024 7:30 am - 9:00 am PST

October 7, 2024 7:30 am - 9:00 am PST

Quarter 1 Meeting

Establish Goals and Objectives:

Define the goals and objectives of the collaborative, such as increasing awareness, improving screening protocols, and enhancing support services for individuals at risk of PMADs.

Cultural Competence and Inclusivity:

Ensure that the collaborative is culturally competent and inclusive, recognizing the unique needs and experiences of diverse populations (who do we need to invite?)

Needs Assessment:

Identify the local or regional needs for PMAD screening and support. This may involve reviewing existing data on PMAD prevalence, healthcare infrastructure, and available resources.

Quarter 2 Meeting

Appreciative Inquiry Method:

What is it and what does it look like in practice?

Screening Protocols:

Develop or adopt evidence-based screening protocols for PMADs. These should be integrated into routine prenatal and postpartum care.

Data Collection and Monitoring:

Implement a system for collecting data on PMAD screening and outcomes. Regularly monitor and evaluate the effectiveness of the screening program.

Referral and Treatment Pathways:

Establish clear referral pathways for individuals who screen positive for PMADs to receive appropriate treatment and support services.

Quarter 3 Meeting

Resource Allocation:

Identify and allocate resources, including funding, staff, and technology, to support the collaborative's activities.

Outreach and Networking:

Reach out to other organizations and professionals who can contribute to the collaborative's mission, such as obstetricians, pediatricians, and mental health providers.

Sustainability:

Develop a plan for the long-term sustainability of the collaborative, including strategies for adding members and increasing support across disciplines.

Legal and Ethical Considerations:

Address legal and ethical issues related to PMAD screening, data privacy, and informed consent.

Quarter 4 Meeting

Community Engagement:

Engage with the community to gather feedback, build trust, and ensure that the collaborative's efforts align with the needs and preferences of the community.

Documentation and Reporting:

Maintain clear and comprehensive documentation of collaborative activities, outcomes, and impact, which may be required for reporting to funders or stakeholders.

Public Awareness Campaigns:

Develop public awareness campaigns to reduce stigma and increase awareness of PMADs. These campaigns can help individuals recognize the symptoms and seek help.

Evaluation and Improvement:

Regularly assess the collaborative's performance and make necessary improvements to enhance the quality and impact of the PMAD screening and support efforts.